Fady Ibraham Malik - Mar 5, 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John Faurescu, attorney-in-fact for Dr. Malik
Stock symbol
CYTK
Transactions as of
Mar 5, 2024
Transactions value $
-$2,011,818
Form type
4
Date filed
3/5/2024, 04:05 PM
Previous filing
Mar 7, 2024
Next filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Sale -$270K -4K -2.8% $67.53 139K Mar 5, 2024 Direct F1
transaction CYTK Common Stock Options Exercise $191K +28.6K +20.58% $6.67* 168K Mar 5, 2024 Direct F1
transaction CYTK Common Stock Sale -$1.93M -28.6K -17.07% $67.56 139K Mar 5, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -28.6K -50% $0.00 28.6K Mar 5, 2024 Common Stock 28.6K $6.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.